期刊文献+

TRFIA螯合剂中间体2,6-二(3′-溴甲基-1′-吡唑基)-4-溴吡啶的合成、分离与表征

Synthesis,Separation and Characterization of TRFIA Chelates Intermediate 4-Bromo-2,6-bis(3-(bromomethyl)-1H-pyrazol-1-yl)pyridine
下载PDF
导出
摘要 以2,6-二(3-甲基-1-H-吡唑基)-4-溴吡啶为原料,经重氮化、溴化合成了新型时间分辨荧光免疫分析(TR-FIA)双功能螯合剂中间体2,6-二(3′-溴甲基-1′-吡唑基)-4-溴吡啶,通过IR、GC-MS1、HNMR和元素分析等对其结构进行了确认,探讨了合成条件及反应机理。同时,通过GC-MS1、HNMR和元素分析等对第一副产物4-溴-2-(3′-溴甲基-1′-吡唑基)-6-(3′-甲基-1′-吡唑基)吡啶的结构也进行了确认,以其为原料可继续合成目标化合物,大幅提高总产率。 A new bifunctional chelate intermediate of time-resolved fluorescence immunoassay 4-bromo-2,6- bis(3-(bromomethyl)-1H-pyrazol-1-yl)pyridine was prepared from 4-bromo-2,6-bis(3-methyl-lH-pyrazol-1-yl) pyridine by diazotizing reaction and brominating reaction. The structure of the product was determined by IR,^1 HNMR,GC-MS and elemental analysis. The reaction conditions and reaction mechanism were also researched. At the same time, the main outgrowth 4-bromo-2-(3-(bromomethyl)-lH-pyrazol-1-yl)-6-(3-methyl-1H- pyrazol-1-yl)pyridine was separated and its structure was determined by ^1HNMR,GC-MS and elemental analysis as well. And the target product could also be prepared from it, so the yield was increased greatly.
出处 《化学与生物工程》 CAS 2009年第6期40-42,共3页 Chemistry & Bioengineering
基金 国家自然科学基金资助项目(30471606)
关键词 时间分辨荧光免疫分析(TRFIA) 2 6-二(3'-溴甲基-1'-吡唑基)-4-溴吡啶 4-溴-2-(3'-溴甲基-1'-吡唑基)-6-(3'-甲基-1'-吡唑基)吡啶 螯合剂 time-resolved fluorescence immunoassay (TRFIA) 4-bromo-2, 6-bis ( 3-( bromomethyl )-1H- pyrazol- 1-yl) pyridine 4-bromo-2-( 3-( bromomethyl )-1 H-pyrazol-1-yl )-6-( 3-methyl-1 H-pyrazol-1-yl ) pyridine chelate
  • 相关文献

参考文献5

  • 1Wu Feng-Bo, Han Shi-Quan, Xu Tao, et al. Sensitive time-resolved fluoroimmunoassay for simultaneous detection of serum thyroidstimulating hormone and total thyroxin with Eu and Sm as labels[J]. Analytical Biochemistry,2003, 314(1) : 87-96.
  • 2李跃松,黄飚,朱岚,张祥瑞,武红玉,裴豪,肖华龙.β_2微球蛋白时间分辨荧光免疫检测法的建立及初步应用[J].现代免疫学,2005,25(1):53-55. 被引量:2
  • 3石竹,李宏涛,李新,潘利华,刘婷婷.2,6-二(3-甲基-1-H-吡唑)-4-溴吡啶的合成与表征[J].长春工业大学学报,2008,29(1):14-17. 被引量:1
  • 4王葆仁.有机合成反应[M].北京:科学出版社,1985:10-30.
  • 5Henke B R, Aquino C J, Birkemo L S, et al. Optimization of 3- (1H-indazol-3-ylmethyl)-1, 5-benzodiazepines as potent, orally active CCK-A agonists [J]. J Med Chem, 1997, 40 ( 17 ) : 2706- 2725.

二级参考文献11

  • 1吴德福.四参数Logistic函数的简化求解[J].中华核医学杂志,1990,10:48-48.
  • 2Diamandis EP. Immunoassay with time-resolved fluorescence spectroscopy: principles and application[J]. Clin Biochem, 1988,21:139-150.
  • 3黄文宁 刘华.《实用医学分析技术与应用》[M].北京人民卫生出版社出版,2002.250-253.
  • 4Soini E, Hemmila I. Fluoroimmunoassay: present status and key problems[J]. Clin. Chem. , 1979,25: 353-355.
  • 5Soini E, Kojola H. Time resolved fluorometer for lanthanide chelates: A new generation on nonisotopic immunoassays[J]. Clin. Chem. , 1983,29 : 65- 68.
  • 6Nesmeyanov A N, Kochetkov N K, Rybinskaya M I. Synthesize of pyrazoles[J]. Izvest Akad Nauk SSSR, Otdel, Khim. Nank,1950:350-356.
  • 7Yuan J L, Wang G L, Matsumoto K. Synthesis of a terbium fluorescent chelate and its application to time-resolved fluoroimmunoassay[J]. Anal. Chem. , 2001,73:1 869-1 876.
  • 8张民军,叶伟民,陆慧琦,仲人前.β_2-微球蛋白在恶性实体瘤诊断中的价值[J].上海医学检验杂志,2001,16(3):169-169. 被引量:17
  • 9胡名扬,梁高林,虞燕华,黄飚,金坚.时间分辨荧光免疫分析中β-NTA及其增强液的制备[J].中华核医学杂志,2001,21(4):244-245. 被引量:7
  • 10姜傥.尿液蛋白与肾脏病[J].中华检验医学杂志,2002,25(5):312-313. 被引量:91

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部